Trading Ideas

Insider buying can be an encouraging signal for potential investors.A red-hot cult stock saw a beneficial owner adding to its stake this week.Some insiders were making purchases in the wake of earnings reports.Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. So insider buying can be an encouraging signal for potential investors, particularly during periods of uncertainty.Insiders continued to add shares despite overall market volatility and global economic gloom. Here are some of the most noteworthy insider purchases …read more […]

The coronavirus pandemic has decimated the rental car business, which also hurts automakers. Hertz says it won’t need to buy any new vehicles in 2020. …read more […]

Avianca Holdings SA, Latin America’s second-largest airline, filed for Chapter 11 bankruptcy on Sunday, as a bond payment deadline loomed and after unsuccessfully pursuing emergency aid from Colombia’s government to survive the coronavirus crisis. Avianca estimated liabilities between $1 billion to $10 billion in a filing with the U.S. Bankruptcy Court for the Southern District of New York. “Avianca is facing the most challenging crisis in our 100-year history,” CEO Anko van der Werff said in a press release. …read more […]

Germany is working on a “concrete model” to aid Lufthansa, Economy Minister Peter Altmaier said on Sunday, amid a political row over whether the state should take a strategic shareholding and play an active role in the stricken airline. Altmaier’s comments followed calls by the Social Democratic Party, junior partners in Chancellor Angela Merkel’s ruling coalition, to tie aid for Lufthansa to protecting jobs, cutting the dividend and giving the government a say on strategy. …read more […]

…read more […]

Hedge funds don’t get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don’t realize is that 100% of the passive funds didn’t see the coronavirus recession coming, but a lot of hedge funds did. Even we published an article near the end of February and […] …read more […]

From unemployment benefits to stimulus checks to withdrawals from retirement accounts, coronavirus relief measures could hit your taxes next year. …read more […]

…read more […]

It’s been a pretty great week for Inphi Corporation (NYSE:IPHI) shareholders, with its shares surging 20% to US$111 in… …read more […]

COVID-19 and its impact on the U.S. economy will continue to take center stage in the week ahead. …read more […]

President Donald Trump is hoping to persuade a Supreme Court with two of his appointees to keep his tax and other financial records from being turned over to lawmakers and a New York district attorney. The justices are hearing arguments by telephone Tuesday in a pivotal legal fight that could affect the presidential campaign, even with the coronavirus outbreak and the resulting economic fallout. Rulings against the president could result in the quick release of personal financial information that Trump has sought strenuously to keep private. …read more […]

Stocks are on the rise, but why? The glum results of earnings season have not caused another panic – rather, investors seem to be taking them in stride as ‘baked in’ to the current financial situation. The indexes are generally holding steady, at resistance levels Wall Street had predicted two weeks ago. And this brings up the questions, How long will this last? and What will happen next? Weighing in from Morgan Stanley, chief US equity strategist Michael Wilson believes that stocks hit their true bottom on March 23. In his view, the coronavirus and the collapse in oil markets …read more […]

The U.S. Food and Drug Administration (FDA) approved a treatment developed by AstraZeneca (AZN) and Merck Co. (MRK) for advanced ovarian cancer.The FDA approved the ovarian drug Lynparza to be used in combination with bevacizumab as a first-line maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. Patients will be selected for therapy based on an FDA-approved companion diagnostic for Lynparza.Lynparza is a first-in-class PARP inhibitor, which is a targeted treatment to potentially exploit DNA damage response (DDR) pathway deficiencies, such as so-called BRCA mutations to kill cancer cells. It is being tested in …read more […]

Last week saw the newest quarterly earnings release from Bristol-Myers Squibb Company (NYSE:BMY), an important… …read more […]

As you might know, Bill.com Holdings, Inc. (NYSE:BILL) just kicked off its latest quarterly results with some very… …read more […]